Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Lesinurad

Brand: Zurampic┬«
NICE TA: 506
Indication: Treating chronic hyperuricaemia in people with gout (NICE TA506)
Disease category: Musculoskeletal system
Commissioning responsibility: CCG
PbR excluded: No

Background

Lesinurad is not recommended within its marketing authorisation, that is, with a xanthine oxidase inhibitor for treating hyperuricaemia in adults with gout whose serum uric acid is above the target level despite an adequate dose of a xanthine oxidase inhibitor alone.

Recommendation

LMMG recommendation: Black
Click here to find the definitions for the colour classifications

Reason for decision:  Not recommended for prescribing on the NHS in Lancashire

Supporting documents:

NICE TA506 - Lesinurad for treating chronic hyperuricaemia in people with gout

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black